Monitoring digoxin therapy: III. How useful are the nomograms?

Monitoring digoxin therapy: III. How useful are the nomograms?

1. A previously described set of guidelines for digoxin therapy has been evaluated in twenty-four patients. 2. Six different published methods (nomograms and equations) for predicting digoxin requirements have been studied to determine their clinical usefulness in the context of the twenty-four pati...

Bibliografski detalji
Glavni autor:	Aronson, J
Format:	Journal article
Jezik:	English
Izdano:	1978

Slični predmeti

Monitoring digoxin therapy. The use of plasma digoxin concentration measurements in the diagnosis of digoxin toxicity.
od: Aronson, J, i dr.
Izdano: (1978)

ABC of monitoring drug therapy. Digoxin.
od: Aronson, J, i dr.
Izdano: (1992)

Monitoring digoxin therapy: II. Determinants of the apparent volume of distribution.
od: Aronson, J, i dr.
Izdano: (1977)

Digoxin revisited.
od: Aronson, J
Izdano: (1998)

Interaction of digoxin with quinine.
od: Aronson, J, i dr.
Izdano: (1981)

MONITORING OF SERUM DIGOXIN CONCENTRATION AND SAFETY OF THERAPY WITH DIGOXIN IN PATIENTS WITH ATRIAL FIBRILLATION
od: S. F. Zadvorev, i dr.
Izdano: (2018-05-01)

Clinical pharmacokinetics of digoxin 1980.
od: Aronson, J
Izdano: (1980)

Monitoring digoxin therapy: I. Plasma concentrations and an in vitro assay of tissue response.
od: Aronson, J, i dr.
Izdano: (1977)

The characteristics of the binding of 12-alpha-[3H]-digoxin to the membranes of intact human erythrocytes: relevance to digoxin therapy.
od: Ford, A, i dr.
Izdano: (1979)

DIAGNOSING DIGOXIN TOXICITY BY COMBINED MEASUREMENT OF PLASMA DIGOXIN CONCENTRATIONS AND ERYTHROCYTIC RB-86 UPTAKE
od: Aronson, J, i dr.
Izdano: (1983)

Indications for the measurement of plasma digoxin concentrations.
od: Aronson, J
Izdano: (1983)

The use of colour vision measurement in the diagnosis of digoxin toxicity.
od: Aronson, J, i dr.
Izdano: (1980)

Appropriateness of digoxin level monitoring
od: MR Mordasini, i dr.
Izdano: (2002-09-01)

Digoxin-like factor in infants of diabetic mothers not receiving digoxin therapy
od: M Yurdakök, i dr.
Izdano: (1989-10-01)

Drug therapy monitoring (TDM) of Digoxin: safety and efficacy review
od: Rony Abdi Syahputra, i dr.
Izdano: (2022-04-01)

In vivo cation transport during short-term and long-term digoxin therapy.
od: Boon, N, i dr.
Izdano: (1986)

EVIDENCE THAT CATION-TRANSPORT INVIVO IS INHIBITED BY SHORT-TERM BUT NOT LONG-TERM DIGOXIN THERAPY
od: Boon, N, i dr.
Izdano: (1984)

The acute changes seen in cardiac glycoside receptor sites, 86rubidium uptake and intracellular sodium concentrations in the erythrocytes of patients during the early phases of digoxin therapy are not found during chronic therapy: pharmacological and therapeutic implications for chronic digoxin therapy.
od: Ford, A, i dr.
Izdano: (1979)

ERYTHROCYTIC DIGOXIN RECEPTOR NUMBERS AND ACTIVITY - RELATION TO CLINICAL CHANGES FOLLOWING DIGOXIN WITHDRAWAL AFTER LONG-TERM TREATMENT FOR HEART-FAILURE IN SINUS RHYTHM
od: Pugh, S, i dr.
Izdano: (1982)

THE EFFECT OF DIGOXIN ON THE INVIVO DISPOSITION OF AN ORAL LOAD OF RUBIDIUM CHLORIDE
od: Aronson, J, i dr.
Izdano: (1982)

Characterizing Utilization and Outcomes of Digoxin Immune Fab for Digoxin Toxicity
od: Sophia Sheikh, i dr.
Izdano: (2024-06-01)

Severe digoxin intoxication: A case report of the use of digoxin-specific Fab antibody fragments
od: Tadej Petreski, i dr.
Izdano: (2023-08-01)

Ten Years of Experience in Treating Patients With Digoxin Toxicity Without Using Digoxin Fab Antibody
od: Farzad Gheshlagh, i dr.
Izdano: (2021-01-01)

Pharmacokinetic monitoring of chronic treatment with digoxin from Primary Health Care
od: Emma M García-Iranzo, i dr.
Izdano: (2017-07-01)

Effects of Age, Gender, and Comorbid Diseases on Serum Digoxin Levels During Digoxin Treatment
od: Zeynep ÖZTÜRK, i dr.
Izdano: (2018-01-01)

Serum digoxin concentrations in dogs with atrial fibrillation under long term digoxin treatment
od: Antonella Colella, i dr.
Izdano: (2022-06-01)

Neglected facts in digoxin intoxication
od: Sibel Ocak Serin
Izdano: (2017-06-01)

The effects of digoxin and dopamine on the oxygen consumption, lactate production and performance of an isolated, perfused working guinea-pig heart
od: Zannad, F, i dr.
Izdano: (1982)

THE EFFECTS OF DIGOXIN AND DOPAMINE ON THE OXYGEN-CONSUMPTION, LACTATE PRODUCTION AND PERFORMANCE OF AN ISOLATED, PERFUSED WORKING GUINEA-PIG HEART
od: Zannad, F, i dr.
Izdano: (1982)

Treatment with Digoxin – is it a clinical challenge? A Retrospective Analysis of Hospitalizations due to Digoxin intoxication
od: Marcin Wais, i dr.
Izdano: (2024-04-01)

The effects of digoxin and dopamine on the oxygen consumption, lactate production and haemodynamic performance of an isolated, perfused, working guinea-pig heart.
od: Zannad, F, i dr.
Izdano: (1982)

A study of the transport of lithium across the erythrocyte membrane in vivo and of the effects of the ion transport inhibitors digoxin and dipyridamole.
od: Wood, A, i dr.
Izdano: (1989)

Digoxin for Atrial Fibrillation in Spinal Anesthesia
od: Maryam Vosoughian, i dr.
Izdano: (2024-03-01)

Preparation of Nanoparticles of Digoxin Solid Lipid
od: Ping Luo, i dr.
Izdano: (2017-12-01)

Inadvertent Intrathecal Administration of Digoxin, with Review of the Literature
od: Burton J. Tabaac, i dr.
Izdano: (2023-01-01)

Review: Failure of current digoxin monitoring for toxicity: new monitoring recommendations to maintain therapeutic levels for efficacy
od: Sridhar Rao Gona, i dr.
Izdano: (2023-07-01)

OPTIMIZATION OF THE HEART RATE CONTROL IN ATRIAL FIBRILLATION BY MONITORING OF THE DIGOXIN CONCENTRATION IN ELDERLY PATIENTS
od: S. F. Zadvorev, i dr.
Izdano: (2018-07-01)

Effect of Digoxin Therapy on Mortality in Patients With Atrial Fibrillation: An Updated Meta-Analysis
od: Xiaoxu Wang, i dr.
Izdano: (2021-10-01)

The effect of cholestyramıne on dogs with acute digoxin toxicosis
od: Abdullah Başoğlu, i dr.

Digoxin and Heart Failure: Are We Clear Yet?
od: Amit Gupta, i dr.
Izdano: (2017-04-01)